OMRON Corporation

OMRON Corporation

28.91
USD
-2.08
(-6.71%)
1.86EPS
26.96P/E
8.02BMarket Cap
Jan 28Next Earn
OMRON Corporation
OTC:OMRNY
(OTC Markets)

Recent

price

28.91

P/E

ratio

26.96

div

yld

2.28%

ROIC.AI

2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
2026
TTM
JPY
2,804.45
2,812.37
2,952.62
3,508.88
3,865.82
3,856.56
3,711.69
4,038.79
3,514.14
3,303.95
3,247.63
3,794.95
4,411.27
4,155.76
3,630.39
3,897.45
4,059.76
Revenue per Share
121.57
74.41
137.1
209.66
283.67
218.78
214.92
296.62
260.58
364.98
214.55
305.42
371.91
41.14
82.57
144.69
238.01
Basic EPS, GAAP
190.45
145.04
240.84
358.82
351.59
389.57
363.95
346
341.76
437.55
464.86
335.4
269.16
227.77
283.09
309.41
534.35
Free Cash Flow per Basic Share
23.99
29.98
27.98
47.96
59.25
74.38
67.95
72.22
80.47
84.06
83.98
88.31
95.23
100.93
103.9
103.93
103.89
Dividend per Share
1,419.94
1,456.62
1,665.75
1,954.56
2,252.63
2,078.38
2,192.03
2,398.52
2,453.35
2,624.6
3,006.83
3,337.07
3,686.98
3,991.96
3,917.27
4,247.79
4,251.46
Book Value per Share
1,419.94
1,456.62
1,665.75
1,954.56
2,212.27
1,936.99
2,050.02
2,214.88
2,256.13
2,433.75
2,812.81
3,137.82
3,239.71
1,603.62
1,504.6
1,683.59
2,285.18
Tangible Book Value per Share
220
220
220
220
219
216
214
213
208
205
202
201
199
197
197
197
197
Basic Weighted Avg Shares
617,825
619,461
650,461
772,966
847,252
833,604
794,201
859,982
732,581
677,980
655,529
762,927
876,082
818,761
715,379
767,351
799,167
Sales/Revenue/Turnover
7.78
5.42
6.34
8.02
10.31
7.88
8.25
9.69
9
7.65
9.93
11.37
11.23
4.27
7.96
7.19
9.12
Operating Margin (%)
22,984
22,617
22,452
25,089
28,339
31,460
28,966
29,465
30,459
28,605
22,756
23,367
26,587
30,816
33,450
33,778
40,780
Depreciation Expense
26,782
16,389
30,203
46,185
62,170
47,290
45,987
63,159
54,323
74,895
43,307
61,400
73,861
8,105
16,271
28,487
46,853
Net Income, GAAP
34.75
53.14
34.18
31.41
33.06
30.51
30.36
25.93
25.82
21.74
23.19
26.58
25.35
30
46.35
25.61
21.91
Effective Tax Rate (%)
4.33
2.65
4.64
5.98
7.34
5.67
5.79
7.34
7.42
11.05
6.61
8.05
8.43
0.99
2.27
3.71
5.86
Profit Margin (%)
146,458
155,201
187,993
233,786
257,334
226,946
263,823
254,607
284,418
295,840
353,062
271,233
276,872
316,443
306,219
305,859
324,747
Working Capital
849
- -
- -
- -
- -
- -
- -
- -
- -
19,820
27,709
28,567
33,284
130,374
146,129
107,020
105,004
LT Debt
313,652
321,680
368,763
432,778
492,094
447,034
470,757
507,386
506,311
532,589
609,358
667,971
731,227
950,993
934,432
1,000,562
869,028
Total Equity
8.83
4.48
7.59
10.45
12.55
9.65
9.82
12.49
9.32
7.36
8.22
9.2
9.67
2.55
2.55
3.77
5.22
Return on Invested Capital (%)
7.53
4.69
8.47
11.41
13.38
9.99
9.95
12.84
10.3
13.57
7.05
8.83
9.73
0.66
1.58
2.18
4.09
Return on Capital (%)
8.65
5.17
8.78
11.58
13.51
10.12
10.07
12.96
10.76
14.48
7.62
9.65
10.6
1.07
2.09
3.54
5.8
Return on Common Equity (%)

Capital Structure

JPY

•

in mil. unless spec.
Mar'26
Jun'27
Sep'27
ST Debt
134,189
164,963
133,812
LT Borrowings
75,910
77,078
75,314
LT Finance Leases
31,110
30,877
29,690
Preferred Equity and Hybrid Capital
- -
- -
- -
Shares Outstanding
197
197
197
Market Capitalization
896,187
1,152,284
1,262,692

Working Capital

JPY

•

in mil. unless spec.
Mar'26
Jun'27
Sep'27
Total Current Assets
676,108
716,567
690,310
Cash, Cash Equivalents & STI
166,541
224,273
177,882
Accounts Receivable, Net
168,586
158,645
159,585
Inventories
154,215
161,117
172,209
Total Current Liabilities
370,249
372,215
365,563
Payables & Accruals
- -
- -
- -
ST Debt
134,189
164,963
133,812
Deferred Revenue
- -
- -
- -

Growth Rates

JPY

•

in mil. unless spec.

(avg. rate of change)

10 years
5 years
1 year
Total Equity
8.7%
10.9%
7.08%
Free Cash Flow
-1.71%
-6.28%
9.21%
Net Income, GAAP
16.51%
29.77%
75.08%
Sales/Revenue/Turnover
-0.27%
3.86%
7.26%
Total Cash Common Dividend
2.57%
3.86%
-0.06%

Quarterly Revenue

JPY

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2025
183,713
190,925
205,060
222,055
715,379
2026
166,480
203,971
220,840
153,063
767,351
2027
209,864
215,400
- -
- -
- -

Quarterly Earnings Per Share

JPY

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2025
-48.85
32.04
53.33
46.16
82.57
2026
23.35
11.35
26.91
71.96
144.69
2027
54.04
85.01
- -
- -
- -

Quarterly Dividends Per Share

JPY

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2025
49.58
2.37
49.85
2.15
103.9
2026
49.69
2.27
49.91
2.09
103.93
2027
49.98
1.98
- -
- -
- -
Business
OMRON Corporation (6645.T), founded in 1933 and headquartered in Kyoto, Japan, develops, manufactures, and sells automation components, control equipment, electronic devices, healthcare products, and social infrastructure systems worldwide, with primary operations in Japan, the Americas, Europe, Asia, and other regions. The company operates through key segments including Industrial Automation Business, offering factory automation systems, programmable controllers, sensors, motion drives, robotics, safety components, and vision systems; Device and Module Solutions Business, providing relays, switches, connectors, and sensors; Healthcare Business, supplying blood pressure monitors, nebulizers, digital thermometers, body composition monitors, and respiratory care devices; Social Systems, Solutions and Service Business, delivering energy management, public transport systems, traffic safety solutions, network protection, payment systems, and infrastructure monitoring; and Data Solutions Business, focusing on digital transformation services. OMRON maintains a global presence with subsidiaries and facilities supporting manufacturing and sales across multiple continents. Recent developments include the launch of the Bengaluru Automation Center in India in October 2025 to advance smart manufacturing and skill development; the announcement in September 2025 to consider spinning off the Device & Module Solutions Business by April 2026 to enhance agility; the acquisition of iCARE in September 2025 to expand into corporate health solutions; a strategic partnership with Japan Activation Capital in July 2025 under the Structural Reform Program NEXT 2025; investment by OMRON Ventures in Sky Labs in November 2025 for blood pressure monitoring advancements; surpassing 50 million nebulizers sold globally in November 2025; transfer of shares in OMRON Automotive Electronics Italy S.r.l. in December 2025; and release of the Medium-Term Roadmap SF 2nd Stage in November 2025 alongside consolidated financial results for the fiscal half-year.

Company News

  • Omron (OTCMKTS:OMRNY) Stock Price Crosses Above Two Hundred Day Moving Average – Here’s Why

  • Financial Contrast: Omron (OTCMKTS:OMRNY) versus AEye (NASDAQ:LIDR)

  • Omron (OTCMKTS:OMRNY) versus Ralliant (NYSE:RAL) Financial Survey

  • Critical Analysis: A2Z Cust2Mate Solutions (NASDAQ:AZ) and Omron (OTCMKTS:OMRNY)

  • Head to Head Comparison: Omron (OTCMKTS:OMRNY) and Jenoptik (OTCMKTS:JNPKF)

  • OMRNY vs. VPG: Which Stock Is the Better Value Option?

  • Financial Contrast: Omron (OTCMKTS:OMRNY) versus Dais (OTCMKTS:DLYT)

  • OMRNY or VPG: Which Is the Better Value Stock Right Now?

  • Omron (OMRNY) May Find a Bottom Soon, Here's Why You Should Buy the Stock Now

  • OMRNY vs. VPG: Which Stock Is the Better Value Option?

  • Omron (OTCMKTS:OMRNY) Stock Price Up 5.9% – Still a Buy?

  • Omron (OMRNY) Upgraded to Buy: What Does It Mean for the Stock?

  • OMRNY or VPG: Which Is the Better Value Stock Right Now?

  • Oakmark Japan Strategy Q4 2025 Portfolio Review

  • Omron (OTCMKTS:OMRNY) Shares Gap Up – Here’s Why

  • Analyzing Fabrinet (NYSE:FN) & Omron (OTCMKTS:OMRNY)

  • Sky Labs attrae investimenti con la sussidiaria Omron 'OMRON VENTURES'

  • Sky Labs atrae inversiones con la filial 'OMRON VENTURES' de Omron

  • Sky Labs zieht mit Omron-Tochtergesellschaft „OMRON VENTURES" Investitionen an

  • Sky Labs attire les investisseurs avec la filiale d'Omron « OMRON VENTURES »